The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease

Milo A Puhan, Martin Frey, Stefan Büchi, Holger J Schünemann, Milo A Puhan, Martin Frey, Stefan Büchi, Holger J Schünemann

Abstract

Background: Interpretation of the Hospital Anxiety and Depression Scale (HADS), commonly used to assess anxiety and depression in COPD patients, is unclear. Since its minimal important difference has never been established, our aim was to determine it using several approaches.

Methods: 88 COPD patients with FEV1 </= 50% predicted completed the HADS and other patient-important outcome measures before and after an inpatient respiratory rehabilitation. For the anchor-based approach we determined the correlation between the HADS and the anchors that have an established minimal important difference (Chronic Respiratory Questionnaire [CRQ] and Feeling Thermometer). If correlations were >/= 0.5 we performed linear regression analyses to predict the minimal important difference from the anchors. As distribution-based approach we used the Effect Size approach.

Results: Based on CRQ emotional function and mastery domain as well as on total scores, the minimal important difference was 1.41 (95% CI 1.18-1.63) and 1.57 (1.37-1.76) for the HADS anxiety score and 1.68 (1.48-1.87) and 1.60 (1.38-1.82) for the HADS total score. Correlations of the HADS depression score and CRQ domain and Feeling Thermometer scores were < 0.5. Based on the Effect Size approach the MID of the HADS anxiety and depression score was 1.32 and 1.40, respectively.

Conclusion: The minimal important difference of the HADS is around 1.5 in COPD patients corresponding to a change from baseline of around 20%. It can be used for the planning and interpretation of trials.

References

    1. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. International journal of geriatric psychiatry. 2000;15:1090–1096. doi: 10.1002/1099-1166(200012)15:12<1090::AID-GPS249>;2-L.
    1. van Manen JG, Bindels PJ, Dekker FW, CJ IJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57:412–416. doi: 10.1136/thorax.57.5.412.
    1. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127:1205–1211. doi: 10.1378/chest.127.4.1205.
    1. Society AT, Society ER. Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease
    1. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest. 2002;122:1633–1637. doi: 10.1378/chest.122.5.1633.
    1. FitzGerald JM, Haddon JM, Bradly-Kennedy C, Kuramoto L, Ford GT. Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J. 2007;14:145–152.
    1. Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: A systematic review of cognitive behavioural therapy. Br J Health Psychol. 2007
    1. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo. 2004;61:140–147.
    1. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. Journal of psychosomatic research. 2007;63:551–565. doi: 10.1016/j.jpsychores.2007.08.002.
    1. Snaith RP. The Hospital Anxiety And Depression Scale. Health and quality of life outcomes. 2003;1:29. doi: 10.1186/1477-7525-1-29.
    1. Lee JS, Hurley MJ, Carew D, Fisher R, Kiss A, Drummond N. A randomized clinical trial to assess the impact on an emergency response system on anxiety and health care use among older emergency patients after a fall. Acad Emerg Med. 2007;14:301–308.
    1. Schunemann HJ, Guyatt GH. Commentary--goodbye M(C)ID! Hello MID, where do you come from? Health services research. 2005;40:593–597. doi: 10.1111/j.1475-6773.2005.0k375.x.
    1. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health and quality of life outcomes. 2006;4:70. doi: 10.1186/1477-7525-4-70.
    1. Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. Copd. 2005;2:125–129.
    1. Schunemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ) Copd. 2005;2:81–89.
    1. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, Goldstein RS. Pulmonary rehabilitation for chronic obstructive pulmonary disease. CochraneDatabaseSystRev. 2004. p. CD003793.
    1. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clinic proceedings. 2002;77:371–383.
    1. Puhan MA, Busching G, Schunemann HJ, VanOort E, Zaugg C, Frey M. Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Annals of internal medicine. 2006;145:816–825.
    1. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. Journal of psychosomatic research. 1997;42:17–41. doi: 10.1016/S0022-3999(96)00216-4.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778.
    1. Puhan MA, Behnke M, Frey M, Grueter T, Brandli O, Lichtenschopf A, Guyatt GH, Schunemann HJ. Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies. Health and quality of life outcomes. 2004;2:1. doi: 10.1186/1477-7525-2-1.
    1. Puhan MA, Behnke M, Devereaux PJ, Montori VM, Braendli O, Frey M, Schunemann HJ. Measurement of agreement on health-related quality of life changes in response to respiratory rehabilitation by patients and physicians--a prospective study. Respir Med. 2004;98:1195–1202. doi: 10.1016/j.rmed.2004.04.011.
    1. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. Journal of Clinical Epidemiology. 2003;56:1170–1176. doi: 10.1016/S0895-4356(03)00115-X.
    1. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and quality of life outcomes. 2003;1:4. doi: 10.1186/1477-7525-1-4.
    1. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355:362–368. doi: 10.1016/S0140-6736(99)07042-7.
    1. Pallant JF, Bailey CM. Assessment of the structure of the Hospital Anxiety and Depression Scale in musculoskeletal patients. Health and quality of life outcomes. 2005;3:82. doi: 10.1186/1477-7525-3-82.
    1. Wang W, Lopez V, Martin CR. Structural ambiguity of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease. Health and quality of life outcomes. 2006;4:6. doi: 10.1186/1477-7525-4-6.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren